Premier Medical names new chief scientific officer

LabPulse.com staff writers
Jul 27, 2021
2021 07 28 22 21 2792 2021 07 28 Brian Krueger 400

Premier Medical Laboratory Services has named Brian Krueger as its new chief scientific officer.

Krueger, the former technical director of research and development (R&D) at Labcorp, will be responsible for overseeing clinical assay development and communicating with the scientific and customer communities about laboratory capabilities, scientific product development, and the application of scientific research for medical advancements. Brian Krueger. Image courtesy of Premier Medical Laboratory Services.Brian Krueger. Image courtesy of Premier Medical Laboratory Services.
Latest in Research and Development
Sequencing Dna Rna Social
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
March 23, 2023
Clinical Trial Data Network Social
Clinical investigators need to be wary of confounding and bias in real-world studies; here is what to look for and how to address it
March 17, 2023
Hepatitis C Virus Social
National hepatitis C elimination program represents an historic opportunity, according to White House
March 14, 2023
Sequencing Dna Rna Pcr Social
Sophia Genetics partnering with Agilent Technologies to offer cancer analysis solution
March 14, 2023
Related Stories
2020 02 08 00 11 9942 Virus Coronavirus 400
Health Topics
Premier Medical launches Virtual Lab
2020 01 21 22 13 2411 Virus Coronavirus 400
Emergency Use Authorization
Premier Medical to offer coronavirus testing
2019 04 17 00 53 3368 Dna Sequence 400
Product Launch
Premier Medical launches Patia's diabetes genetic test
2020 04 30 22 13 6857 Coronavirus Swab Ppe 400
Clinical Trial
Curebase, InBios tout results of virtual COVID-19 trial
More in Research and Development
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
The lack of a genetic driver of metastatic cancer has led researchers to look for other causes of disease progression.
March 23, 2023
Sequencing Dna Rna Social
Clinical investigators need to be wary of confounding and bias in real-world studies; here is what to look for and how to address it
Clinical investigators need to look out for confounding and bias associated with real-world data in randomized trials and observational studies used to produce real-world evidence (RWE) to assess the safety and efficacy of an intervention.
March 17, 2023
Clinical Trial Data Network Social
National hepatitis C elimination program represents an historic opportunity, according to White House
The Biden-Harris administration proposes a five-year program to expand screening, testing, treatment, and prevention of hepatitis C, focusing on high-risk populations.
March 14, 2023
Hepatitis C Virus Social
Sophia Genetics partnering with Agilent Technologies to offer cancer analysis solution
Through the partnership, the Sophia DDM Platform will be integrated with Agilent’s research-use-only SureSelect Cancer Comprehensive Genomic Profiling (CGP) Assay Kit.
March 14, 2023
Sequencing Dna Rna Pcr Social
PerkinElmer completes divestiture of Applied, Food, and Enterprise Services businesses to New Mountain Capital
The company said that its Life Sciences and Diagnostics business resulting from the divestiture will focus on developing and delivering novel scientific breakthroughs.
March 13, 2023
Business Deal Corporate Social
Racial groups negatively impacted by exclusion from cancer research
Researchers are calling for greater inclusion of people with African ancestry in genomic research to improve prostate cancer outcome disparities.
March 10, 2023
Prostate Cancer Social
Most Popular
Quest launches long-COVID testing panels for consumers
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Patients prefer immediate test results, even when the news is bad
More in Research and Development
Techcyte, Mayo Clinic to collaborate on algorithms for pathology platform
Techcyte’s Clinical Pathology AI Platform, which is CE-marked under IVDR and designated for research use only in the U.S., imports digital images of liquid-based samples from whole-slide scanners.
March 14, 2023
Artificial Intelligence Ai Abstract Social
Convert a smartphone into a fluorescent microscope for under $50
Researchers inexpensively convert smartphones into what they describe as “glowscope” microscopes, potentially enabling underserved students to observe living organisms.
March 9, 2023
Human Cells Flow Cytometry Social
Viz.ai platform to be used in patient enrollment for pulmonary embolism trial
Research institutions participating in the PE-TRACT trial will use the platform, Viz Recruit, to find, screen, and enroll trial candidates.
March 6, 2023
Artificial Intelligence Lung Color Social
Artificial intelligence tool identifies current drugs for future pandemics
Researchers have created an algorithmic tool that calculates how to effectively repurpose current drugs to combat COVID-19 and future pandemics.
March 6, 2023
Covid 19 Pill Social
Illumina, Myriad Genetics provide U.S. access to HRD research test
The expanded partnership establishes a companion diagnostic (CDx) testing alliance for the pharmaceutical industry, which will enable more clinical research for gene-based, targeted therapies, the firms said.
March 6, 2023
Global Collaboration Business Social
Synergy Laboratories taps Sophia Genetics technology for cancer profiling
Synergy Oncology will pair its laboratory technologies with the Sophia DDM for Hereditary Cancers Solution for tumor profiling.
February 28, 2023
Sequencing Dna Rna Social
Page 1 of 30
Next Page